Wingfield H J
Department of Pathology, Hillingdon Hospital, Uxbridge, Middx, U.K.
J Antimicrob Chemother. 1987 Oct;20(4):523-7. doi: 10.1093/jac/20.4.523.
Determination of the MIC of flucytosine for 16 wild isolates of Cryptococcus neoformans and Candida spp. in YNBG medium containing 10 mg/l cytosine demonstrated antagonism of fungistatic activity compared with that determined in YNBG alone. Determination of the MIC in YNBG containing 10 mg/l cytarabine showed no change in activity for 14 of the strains, an increase for one and a decrease for another. Determination of serum flucytosine concentrations in a patient receiving cytarabine simultaneously revealed therapeutic levels. Fluctuations in serum flucytosine concentrations were observed in samples taken before, during and after concurrent cytarabine therapy but these may have resulted from unstable renal function rather than in-vivo inactivation of flucytosine by cytarabine. These data do not support significant antagonism of the fungistatic activity of flucytosine by cytarabine.
在含有10mg/l胞嘧啶的YNBG培养基中,对16株新型隐球菌野生分离株和念珠菌属进行氟胞嘧啶的最低抑菌浓度(MIC)测定,结果显示与仅在YNBG中测定相比,其抑菌活性存在拮抗作用。在含有10mg/l阿糖胞苷的YNBG中进行MIC测定,结果显示14株菌株的活性无变化,1株增加,1株降低。对一名同时接受阿糖胞苷治疗的患者的血清氟胞嘧啶浓度进行测定,结果显示为治疗水平。在同时进行阿糖胞苷治疗之前、期间和之后采集的样本中观察到血清氟胞嘧啶浓度波动,但这些波动可能是由于肾功能不稳定,而非阿糖胞苷导致氟胞嘧啶在体内失活。这些数据不支持阿糖胞苷对氟胞嘧啶抑菌活性有显著拮抗作用。